Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Stahl

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 7, 2012
Multimodal therapy of GEJ cancer: when is the definitive radiochemotherapy the treatment of choice?Michael Stahl
Journal of Thoracic Disease|August 18, 2017
Definitive chemoradiotherapyMichael Stahl, Wilfried Budach
Translational Vision Science & Technology|September 5, 2020
Structured Laser Light Improves Tripping Hazard Recognition for People with Visual ImpairmentsMichael Stahl, Eli Peli
Journal of Hazardous Materials|December 25, 2003
Hydrocode simulations of air and water shocks for facility vulnerability assessmentsJ Keith Clutter, Michael Stahl
Bioanalysis|September 19, 2017
Demonstrating biosimilar and originator antidrug antibody binding comparability in antidrug antibody assays: a practical approachJanka Ryding, Michael Stahl, Martin Ullmann
Journal of Virology|October 5, 2007
Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA bindingMichael Stahl, Jürgen Beck, Michael Nassal
Onkologie|September 15, 2005
Second-line chemotherapy of advanced disseminated gastric cancer after cisplatin, infusional 5-fluorouracil, folinic acid (PLF): benefit dependent on progression-free interval after first-line therapyMichael Stahl, Christian Müller, Wolf Köster, et al.
Journal of Bacteriology|February 19, 2008
Lgt: a family of cytotoxic glucosyltransferases produced by Legionella pneumophilaYury Belyi, Irina Tabakova, Michael Stahl, et al.
Nucleic Acids Research|September 7, 2007
Chaperone activation of the hepadnaviral reverse transcriptase for template RNA binding is established by the Hsp70 and stimulated by the Hsp90 systemMichael Stahl, Marco Retzlaff, Michael Nassal, et al.
Journal of Cancer Research and Clinical Oncology|March 16, 2006
Lack of prognostic impact of p53 gene mutation and p53 phosphorylation at serine 15 in multimodally treated adenocarcinomas of the gastroesophageal junctionFranziska Pühringer-Oppermann, Michael Stahl, Gisela Keller, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 7, 2012
Multimodal therapy of GEJ cancer: when is the definitive radiochemotherapy the treatment of choice?Michael Stahl
Journal of Thoracic Disease|August 18, 2017
Definitive chemoradiotherapyMichael Stahl, Wilfried Budach
Translational Vision Science & Technology|September 5, 2020
Structured Laser Light Improves Tripping Hazard Recognition for People with Visual ImpairmentsMichael Stahl, Eli Peli
Journal of Hazardous Materials|December 25, 2003
Hydrocode simulations of air and water shocks for facility vulnerability assessmentsJ Keith Clutter, Michael Stahl
Bioanalysis|September 19, 2017
Demonstrating biosimilar and originator antidrug antibody binding comparability in antidrug antibody assays: a practical approachJanka Ryding, Michael Stahl, Martin Ullmann
Journal of Virology|October 5, 2007
Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA bindingMichael Stahl, Jürgen Beck, Michael Nassal
Onkologie|September 15, 2005
Second-line chemotherapy of advanced disseminated gastric cancer after cisplatin, infusional 5-fluorouracil, folinic acid (PLF): benefit dependent on progression-free interval after first-line therapyMichael Stahl, Christian Müller, Wolf Köster, et al.
Journal of Bacteriology|February 19, 2008
Lgt: a family of cytotoxic glucosyltransferases produced by Legionella pneumophilaYury Belyi, Irina Tabakova, Michael Stahl, et al.
Nucleic Acids Research|September 7, 2007
Chaperone activation of the hepadnaviral reverse transcriptase for template RNA binding is established by the Hsp70 and stimulated by the Hsp90 systemMichael Stahl, Marco Retzlaff, Michael Nassal, et al.
Journal of Cancer Research and Clinical Oncology|March 16, 2006
Lack of prognostic impact of p53 gene mutation and p53 phosphorylation at serine 15 in multimodally treated adenocarcinomas of the gastroesophageal junctionFranziska Pühringer-Oppermann, Michael Stahl, Gisela Keller, et al.
Pageof 7